Market Cap 380.27Cr 101.23Cr 88Cr 83Cr 76Cr 141.81Cr 9.71TCr 142.4Cr 998.39Cr 385.28Cr 4.94TCr 371.82Cr 16TCr P/E 2026 *
16.9x
P/E 2027 * 14.8x
Enterprise Value 478.48Cr 127.37Cr 111.07Cr 104.87Cr 95Cr 178.43Cr 12TCr 179.18Cr 1.26TCr 484.78Cr 6.21TCr 467.85Cr 20TCr EV / Sales 2026 *
2.63x
EV / Sales 2027 * 2.42x
Free-Float
88.97%
Yield 2026 *
1.5%
Yield 2027 * 2.86%
1 day-3.28%
1 week+3.11%
Current month+5.08%
1 month+1.59%
3 months+10.78%
6 months+10.32%
Current year+22.26%
1 week 30.16
Extreme 30.16
33
1 month 30
Extreme 30
33
Current year 24.96
Extreme 24.96
33.12
1 year 24.96
Extreme 24.96
33.12
3 years 20.94
Extreme 20.94
42.85
5 years 20.94
Extreme 20.94
49.35
10 years 20.94
Extreme 20.94
61.4
Manager TitleAgeSince
Chief Executive Officer 58 05/01/2021
Chief Executive Officer - 07/04/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 03/04/2016
Director/Board Member - 03/04/2019
Director/Board Member - 03/04/2019
Change 5-day change 1-year change 3-year change Capi.($)
-3.28%+3.11%+14.19%-6.84% 104.66Cr
+0.04%+3.34%+53.32%+102.40% 1,02800Cr
-0.09%+1.66%+53.24%+65.73% 65TCr
-0.02%+2.66%+18.65%+71.84% 47TCr
-1.22%+3.66%+34.59%+39.32% 35TCr
-0.79%+2.73%+17.73%+23.91% 27TCr
+0.58%+6.76%+10.58%+14.16% 26TCr
+1.55%+2.20%+35.12%+42.07% 21TCr
+0.79%+1.84%-27.55%-57.51% 19TCr
-0.52%+4.45%+31.57%+97.98% 19TCr
Average -0.30%+3.27%+24.14%+39.30% 36.03TCr
Weighted average by Cap. -0.04%+3.09%+34.84%+61.39%

Financials

2026 *2027 *
Net sales 181.77Cr 48Cr 42Cr 40Cr 36Cr 68Cr 4.64TCr 68Cr 477.25Cr 184.17Cr 2.36TCr 177.74Cr 7.6TCr 192.36Cr 51Cr 45Cr 42Cr 38Cr 72Cr 4.91TCr 72Cr 505.05Cr 194.9Cr 2.5TCr 188.09Cr 8.04TCr
Net income 23Cr 6Cr 5.23Cr 4.94Cr 4.49Cr 8.4Cr 575.63Cr 8.44Cr 59Cr 23Cr 292.66Cr 22Cr 941.67Cr 26Cr 6.93Cr 6.04Cr 5.7Cr 5.18Cr 9.7Cr 664.51Cr 9.74Cr 68Cr 26Cr 337.85Cr 25Cr 1.09TCr
Net Debt 98Cr 26Cr 23Cr 22Cr 20Cr 37Cr 2.51TCr 37Cr 257.85Cr 100Cr 1.28TCr 96Cr 4.1TCr 85Cr 23Cr 20Cr 19Cr 17Cr 32Cr 2.16TCr 32Cr 222.18Cr 86Cr 1.1TCr 83Cr 3.54TCr
Logo Saudi Pharmaceutical Industries and Medical Appliances Corporation
Saudi Pharmaceutical Industries and Medical Appliances Corp SPIMACO ADDWAEIH SJSC is a Saudi Arabia based pharmaceutical company. The Company is primarily engaged in manufacturing of pharmaceutical products, medicines for human use and wholesale and retail of medicines and related products, development and marketing of medical and pharmaceutical products, research and development in medical science activities, operating and maintaining the healthcare facilities and any investments in related industries. The Company is organized into four segments which include Pharmaceutical Manufacturing, Trading and Distribution Services, Healthcare Services and Discontinued Operation. Products of the Company include tablets, capsules, syrups and suspensions, injections, creams, ointments and gels, suppositories, mouthwash and antiseptic products. The Subsidiaries of the Company include ARACOM Medical Company, Dammam Pharmaceutical Company, SPIMACO Misr Company for Distribution and others.
Employees
-
Date Price Change Volume
20/26/20 SAR 31.86 -3.28% 2,77,118
17/26/17 SAR 32.94 +8.78% 15,19,026
16/26/16 SAR 30.28 -1.43% 3,54,687
15/26/15 SAR 30.72 -0.78% 2,18,628
14/26/14 SAR 30.96 +0.19% 2,50,227
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
31.86SAR
Average target price
34.05SAR
Spread / Average Target
+6.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2070 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!